Abstract
Telemedicine has always had an openness to the diagnosis and treatment of respiratory diseases. Over the years, pros and cons arguments have been found to mark the benefits or disadvantages of using this tool for COPD patients. We initiated this remote monitoring activities on a small series of patients before the outbreak of the COVID19 epidemic, and this allowed us during these months of physical and social distance to point out the advantages of this method and also determined us to make a transition to review of the latest data in the field related to these types of interventions.